Try The Drug Club risk-free for 30 days Trial terms

Cyclobenzaprine HCl — $0 with Membership

Cyclobenzaprine HCl has an active canonical formulary match. No-additional-cost pricing is subject to its listed supply, quantity, fill, and fulfillment limits.

Cyclobenzaprine HCl Pricing

Pricing typePrice
TheDrugClub$0 with membership
Typical Retail$20.00

Free with membership subject to the listed formulary limits.

About Cyclobenzaprine HCl

Cyclobenzaprine HCl is a prescription medication. Ask your doctor if Cyclobenzaprine HCl is right for you.

Other strengths and forms of Cyclobenzaprine

How to Check Cyclobenzaprine HCl Pricing

  1. Join TheDrugClub for $19.95/month
  2. Receive your member card by email
  3. Present your card at a participating pharmacy
  4. Check active-formulary eligibility or available membership pricing

Cyclobenzaprine HCl at Participating Pharmacies

Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.

About Cyclobenzaprine HCl

Cyclobenzaprine hcl is a widely prescribed medication used to alleviate painful muscle spasms and discomfort. If you're experiencing acute muscle issues, understanding your treatment options and how to access them affordably is crucial. TheDrugClub is dedicated to making essential medications like cyclobenzaprine hcl accessible, often at a $0 co-pay for our valued members.

Cyclobenzaprine hcl is a medication primarily prescribed to relieve muscle spasms associated with acute, painful musculoskeletal conditions. It is often used for short-term treatment, typically for two to three weeks, to help alleviate discomfort from injuries like sprains, strains, or other muscle-related issues. By reducing muscle spasms, it can help improve range of motion and allow individuals to participate more effectively in physical therapy or daily activities. It's important to remember that cyclobenzaprine hcl treats the symptoms of muscle spasm, not the underlying cause of the condition.

This medication belongs to a class of drugs known as skeletal muscle relaxants. Unlike some other muscle relaxants that act directly on the muscle, cyclobenzaprine hcl works centrally. It is

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Cyclobenzaprine HCl is approved for (FDA label)

Cyclobenzaprine hydrochloride tablets, USP are indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. Improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, limitation of motion, and restriction in activities of daily living. Cyclobenzaprine hydrochloride tablets should be used only for short periods (up to 2 or 3 weeks) because adequate evidence of effectiveness for more prolonged use is not available and because muscle spasm associated with acute, painful musculoskeletal conditions is generally of short duration and specific therapy for longer periods is seldom warranted.

Source: Read the full FDA label on DailyMed. Label effective date: September 9, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Cyclobenzaprine HCl (FDA label)

Incidence of most common adverse reactions in the two double-blind*, placebo-controlled 5 mg studies (incidence of > 3% on cyclobenzaprine hydrochloride 5 mg): Cyclobenzaprine Hydrochloride 5 mg Cyclobenzaprine Hydrochloride 10 mg Placebo N = 464 N = 249 N = 469 Drowsiness 29% 38% 10% Dry Mouth 21% 32% 7% Fatigue 6% 6% 3% Headache 5% 5% 8% *Note: Cyclobenzaprine hydrochloride 10 mg data are from one clinical trial. Cyclobenzaprine hydrochloride 5 mg and placebo data are from two studies. Adverse reactions which were reported in 1% to 3% of the patients were: abdominal pain, acid regurgitation, constipation, diarrhea, dizziness, nausea, irritability, mental acuity decreased, nervousness, upper respiratory infection, and pharyngitis.

Source: FDA prescribing information (DailyMed). Set ID: 5d536e88-62be-45bd-bd09-0efc53fe12b9. SPL document ID: 5b11679f-f8ce-f698-e063-6294a90afcf3. Label effective date: September 9, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Cyclobenzaprine HCl (FDA label)

Hypersensitivity to any component of this product. Concomitant use of monoamine oxidase (MAO) inhibitors or within 14 days after their discontinuation. Hyperpyretic crisis seizures and deaths have occurred in patients receiving cyclobenzaprine (or structurally similar tricyclic antidepressants) concomitantly with MAO inhibitor drugs. Acute recovery phase of myocardial infarction, and patients with arrhythmias, heart block or conduction disturbances, or congestive heart failure. Hyperthyroidism.

Source: FDA prescribing information (DailyMed). Set ID: 5d536e88-62be-45bd-bd09-0efc53fe12b9. SPL document ID: 5b11679f-f8ce-f698-e063-6294a90afcf3. Label effective date: September 9, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Start Your Risk-Free Trial
Start Your Risk-Free Trial